Vanguard Global Advisers’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.29M Buy
22,987
+3,593
+19% +$162K ﹤0.01% 1551
2026
Q2
$543K Sell
19,394
-41
-0.2% -$1.15K ﹤0.01% 2062
2026
Q1
$554K Buy
+19,435
New +$663K ﹤0.01% 1990

Other funds holding ATRC

Vanguard Global Advisers's ATRC Position: Q3 2026 in Review

Vanguard Global Advisers increased its AtriCure (ATRC) stake by 19% in Q3 2026, buying an estimated $162K and bringing the position to 22,987 shares worth $1.29M. The position accounts for ﹤0.01% of the portfolio, ranked #1551.

Vanguard Global Advisers first reported a position in ATRC in Q1 2026 and has held it in 3 quarters since. 286 funds tracked by Wall St. Rank hold ATRC as of Q3 2026.

  • Vanguard Global Advisers held 22,987 shares of AtriCure worth $1.29M as of Q3 2026.
  • Vanguard Global Advisers bought 3,593 AtriCure shares in Q3 2026, an estimated $162K.
  • AtriCure made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #1551 holding.
  • Vanguard Global Advisers first reported a position in AtriCure in Q1 2026 and has held it in 3 quarters since.
  • 286 funds tracked by Wall St. Rank held AtriCure as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.